Skip to main content
Log in

Controlled Release of a Contraceptive Steroid from Biodegradable and Injectable Gel Formulations: In Vitro Evaluation

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this study was to investigate the effects of formulation factors including varying wax concentration, drug loading and drug particle size, on drug release characteristics from both pure oil and gel formulations prepared with a combination of derivatized vegetable oil (Labrafil 1944 CS) and glyceryl palmitostearate (Precirol ATO 5), using levonorgestrel as a model drug.

Methods. The effects of varying drug loadings, different drug particle sizes, and wax (Precirol) concentrations on in-vitro drug release rates were evaluated, and the mechanisms of drug release from the gels were determined.

Results. Zero-order drug release rates from the 10% Precirol gel formulations containing 0.25, 0.50 and 2.00% w/v drug loadings were lower than those observed for oil formulations containing identical drug loadings. Higher zero-order release rates were observed from formulations containing smaller drug particles suspended in both oil and gel formulations. The mechanism of drug release from gels containing less than 0.25% w/w drug was diffusion-controlled. Increasing the wax concentrations in the gels from 5% w/w to 20% w/w significantly decreased the diffusivity of the drug through the gel formulations and markedly increased the force required to inject the gels from two different sizes of needles.

Conclusions. This study shows how modification of the physicochemical properties of the gel formulations by changing the drug particle size, wax concentration and drug loading, affects drug release characteristics from the system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. K. Suzuki and J. C. Price. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide). J. Pharm. Sci. 74:21–24 (1985).

    Google Scholar 

  2. R. K. Chang, J. C. Price and C. W. Whitworth. Control of drug release rates through the use of mixtures of polycaprolactone and cellulose propionate polymers. Pharm. Tech. 10:24–33 (1986).

    Google Scholar 

  3. M. Tsakala, J. Gillard, M. Roland, F. Chabot, and M. Vert. Pyrimethamine sustained release systems based on bioresorbable polyesters for chemoprophylaxis of rodent malaria. J. Controlled Rel. 5:233–242 (1988).

    Google Scholar 

  4. Y. Cha and C. G. Pitt. A one-week subdermal delivery system for L-methadone based on biodegradable microcapsules. J. Controlled Rel. 7: 69–78 (1988).

    Google Scholar 

  5. J. P. Benoit, F. Chabot, and M. Veillard. Biodegradable cisplatin microspheres prepared by the solvent evaporation method: Morphology and release characteristics. J. Controlled Rel. 7:217–229 (1988).

    Google Scholar 

  6. N. Leelarasamee, S. A. Howard, C. J. Malanga, and J. K. Ma. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading. J. Microencapsulation. 5:147–157 (1988).

    Google Scholar 

  7. Y. Cha and C. G. Pitt. The acceleration of degradation—controlled drug delivery from polyester microspheres. J. Controlled Rel. 8:259–265 (1989).

    Google Scholar 

  8. F. Koosha, R. H. Muller, S. S. Davis, and M. C. Davies. The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process. J. Controlled Rel. 9:149–157 (1989).

    Google Scholar 

  9. J. M. Ruiz, J. P. Busnel, and J. P. Benoit. Influence of average molecular weights of poly(DL-Lactic Acid-Co-Glycolic Acid) copolymers 50/50 on phase separation and in-vitro drug release from microspheres. Pharm. Res. 7:928–934 (1990).

    Google Scholar 

  10. C. G. Pitt. The Controlled Parenteral Delivery of Polypeptides and Proteins. Int. J. Pharm. (Netherlands) 59(3):173–196 (1990).

    Google Scholar 

  11. K. A. Fults and T. P. Johnston. Sustained-release of urease from a poloxamer gel matrix. J. Parent. Sci. Tech. 44(2):58–65 (1990).

    Google Scholar 

  12. J. L. Zatz, J. P. Berry and D. A. Alderman. Gels. In H. A. Lieberman, M. M. Rieger and G. S. Banker (eds.), Pharamceutical Dosage Forms: Dispersed Systems, Marcel Dekker, New York, 1988, Vol. 2, pp. 495–510.

    Google Scholar 

  13. F. H. Buckwalter. Repository penicillin composition. U.S. Patent #2, 507, 193 (1950).

  14. A. L. Thakkar and R. G. Harrison. Injectable semi-solid formulations, European Patent Application, 86306282.4, (1986).

  15. T. A. Barber. Particle Population Analysis. In Pharmaceutical Particulate Matter, Interpharm Press, Buffalo Grove, Illinois, 1993, pp. 271.

    Google Scholar 

  16. W. Higuchi. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51(8):802–804 (1962).

    Google Scholar 

  17. P. C. Chen-Chow, S. G. Frank. Studies of multiple emulsions as parenteral prolonged release drug delivery systems. Int. J. Pharm. 8:89–99 (1981).

    Google Scholar 

  18. S. C. Chi and H. W. Jun. Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell. J. Pharm. Sci. 80(3):280–283 (1991).

    Google Scholar 

  19. J. C. Gilbert, J. Hadgraft, A. Bye and L. G. Brookes. Drug release from Pluronic F—127 gels. Int. J. Pharm. 32:223–228 (1986).

    Google Scholar 

  20. F. Bottari, G. Di Colo, E. Nanipieri, M. F. Saettone and M. F. Serafini. Influence of drug concentration on in vitro release of salicylic acid from ointment bases. J. Pharm. Sci. 63(11):1779–1783 (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, ZH., Shukla, A.J., Johnson, J.R. et al. Controlled Release of a Contraceptive Steroid from Biodegradable and Injectable Gel Formulations: In Vitro Evaluation. Pharm Res 12, 857–863 (1995). https://doi.org/10.1023/A:1016209020160

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016209020160

Navigation